1. Home
  2. List
Reference Patent

Reference - List

When you enter multiple keywords separated by space, your search will contain results that match any of the keywords (OR search).
  • 35 Hits
  • Search Condition : Filter (MeSH = Drug Resistance, Neoplasm / genetics)
Species Resource Title
Human and Animal Cells GC cell lines Reduced phosphorylation of ribosomal protein S6 is associated with sensitivity to MEK inhibition in gastric cancer cells.
Human and Animal Cells NIH:OVCAR-3(RCB2135) ZNF671 DNA methylation as a molecular predictor for the early recurrence of serous ovarian cancer.
Human and Animal Cells Ba/F3(RCB0805) Dual blockade of EGFR tyrosine kinase using osimertinib and afatinib eradicates EGFR‑mutant Ba/F3 cells.
Human and Animal Cells CW-2(RCB0778) Pan-Cancer Landscape and Analysis of ERBB2 Mutations Identifies Poziotinib as a Clinically Active Inhibitor and Enhancer of T-DM1 Activity.
Human and Animal Cells SAS(RCB1974) , Sa3(RCB0980) , HSC-3(RCB1975) Resveratrol Targets Urokinase-Type Plasminogen Activator Receptor Expression to Overcome Cetuximab-Resistance in Oral Squamous Cell Carcinoma.
Human and Animal Cells Ba/F3 The new-generation selective ROS1/NTRK inhibitor DS-6051b overcomes crizotinib resistant ROS1-G2032R mutation in preclinical models.
Human and Animal Cells Hep G2 Metformin Regulates the Expression of CD133 Through the AMPK-CEBPβ Pathway in Hepatocellular Carcinoma Cell Lines.
Human and Animal Cells EOL-1(RCB0641) miR-217 sensitizes chronic myelogenous leukemia cells to tyrosine kinase inhibitors by targeting pro-oncogenic anterior gradient 2.
Human and Animal Cells Ba/F3(RCB0805) Activity of a novel HER2 inhibitor, poziotinib, for HER2 exon 20 mutations in lung cancer and mechanism of acquired resistance: An in vitro study.
Human and Animal Cells ACC-MESO-1(RCB2292) , ACC-MESO-4(RCB2293) Increased sensitivity to apoptosis upon endoplasmic reticulum stress-induced activation of the unfolded protein response in chemotherapy-resistant malignant pleural mesothelioma.
Human and Animal Cells PC-9(RCB4455) FOXC1 induces cancer stem cell-like properties through upregulation of beta-catenin in NSCLC.
Human and Animal Cells HuCCT1(RCB1960) , TFK-1(RCB2537) Sulforaphane sensitizes human cholangiocarcinoma to cisplatin via the downregulation of anti-apoptotic proteins.
Human and Animal Cells LC-2/ad(RCB0440) , PC-9(RCB4455) AXL and GAS6 co-expression in lung adenocarcinoma as a prognostic classifier.
Human and Animal Cells Lu-165(RCB1184) MYCL is a target of a BET bromodomain inhibitor, JQ1, on growth suppression efficacy in small cell lung cancer cells.
Human and Animal Cells CW-2(RCB0778) Overcoming resistance to HER2 inhibitors through state-specific kinase binding.
Human and Animal Cells HHUA(RCB0658) Lipocalin 2 Enhances Migration and Resistance against Cisplatin in Endometrial Carcinoma Cells.
Human and Animal Cells OMC-3(RCB0755) Regulation of multidrug resistance 1 expression by CDX2 in ovarian mucinous adenocarcinoma.
DNA material pENTR4-H1tetOx1 (RDB07916) , CS-RfA-ETBsd (RDB07917) , CS-RfA-ETV (RDB08020) , CS-RfA-ETR (RDB08362) , CSII-EF-MCS-IRES2-Venus (RDB04384) , CSII-EF-MCS-IRES2-hKO1 (RDB07915). Autonomous feedback loop of RUNX1-p53-CBFB in acute myeloid leukemia cells.
Human and Animal Cells Discovery of biomarkers predictive of GSI response in triple-negative breast cancer and adenoid cystic carcinoma.
Human and Animal Cells Resistance of oral squamous cell carcinoma cells to cetuximab is associated with EGFR insensitivity and enhanced stem cell-like potency.